I sat in the gastroenterologist's office with a referral for an upper endoscopy. My daughter's blood work had already come back positive. Her tissue transglutaminase antibodies were far above the reference range. The doctor still wanted a tissue sample from her small intestine, and I remember wondering why. That question sent me into a stack of medical journal articles, old gastroenterology textbooks, and more than a few late nights with my laptop.

What I learned felt worth sharing, because it changed how I thought about the procedure. Celiac disease has been described in medical texts since the first century AD, when a Greek physician named Aretaeus of Cappadocia wrote about patients with wasting, pale stools, and abdominal distension. He called it koiliakos, from the Greek word for abdomen. For nearly two thousand years after that, diagnosis stayed clinical. Doctors looked at symptoms, tried rice diets or banana diets, and waited to see if a child improved. No one could prove what was happening inside the gut.

How the Small Intestine Biopsy Began

The real leap came in the 1950s, when researchers built a capsule small enough to swallow. The most widely used version arrived in 1957 from William H. Crosby and Henry W. Kugler. A patient swallowed the capsule, about the size of a large vitamin, while a thin tube stayed attached. Once it reached the small intestine, a spring-loaded blade cut off a tiny piece of tissue. Doctors could finally examine a living person's intestinal lining without opening the abdomen. That tool changed everything.

With that tool, celiac diagnosis moved from guesswork to evidence. The tissue sample goes to a pathologist, who stains it and looks at the architecture of the intestinal lining. The most common scoring system is the Marsh classification, named after Michael Marsh, who described the stages of intestinal damage in 1992. Here is how the stages work:

• Marsh 0: Normal lining.
• Marsh 1: More lymphocytes in the lining than usual.
• Marsh 2: Lymphocyte increase plus crypt hyperplasia, meaning more cells are being produced to replace the lining.
• Marsh 3: The classic celiac pattern with partial, subtotal, or total villous atrophy, where the finger-like villi are shortened or flattened.
• Marsh 4: Complete flattening, rare and usually seen in severe cases.

That grading gives a baseline. It tells you how much damage exists before you start a gluten-free diet. Without that baseline, you cannot know later whether healing is happening, because a follow-up biopsy can compare the same structures. Blood antibodies can fall to undetectable levels while the gut lining still needs more time. The tissue sample shows the repair, not just the immune reaction.

Why Blood Tests Do Not Always Close the Case

By the late 1990s and early 2000s, blood testing for celiac became common. Tissue transglutaminase antibodies, endomysial antibodies, and deamidated gliadin peptides made diagnosis far less invasive. Many people hoped the biopsy would become unnecessary. In some cases, it already has.

The European Society for Paediatric Gastroenterology, Hepatology and Nutrition updated its guidelines in 2020. A child can be diagnosed without a biopsy if three conditions line up: tissue transglutaminase antibody levels more than ten times the upper limit of normal, a positive endomysial antibody test on a separate blood draw, and the presence of HLA-DQ2 or HLA-DQ8 genes. Those kids avoid anesthesia and a scope. That is a real shift, and it spares many families a hard procedure.

But for adults and for children who do not meet those strict criteria, the biopsy remains the reference standard. Blood tests can produce false positives and false negatives. Other conditions, including autoimmune thyroid disease and type 1 diabetes, can raise tissue transglutaminase antibodies in people who do not have celiac disease. Some people carry the genetic markers and never develop the condition. The biopsy confirms the damage itself, which blood tests only hint at.

There is also the question of severity. A person with Marsh 1 changes may need a different follow-up plan than someone with Marsh 3c. More severe damage at diagnosis can mean a different monitoring schedule, especially if the pathologist notes subtotal or total villous atrophy. The biopsy provides a level of detail a positive blood test cannot match.

What Might Replace the Scope

Researchers are testing less invasive alternatives. Capsule endoscopy lets a patient swallow a camera the size of a pill, and the camera images the small intestine without sedation. It is already used for other conditions and is being studied for celiac follow-up. Several labs are looking at blood biomarkers that might predict villous atrophy with enough accuracy to replace biopsy in certain groups. Others are studying stool tests for intestinal damage markers.

I do not expect the biopsy to disappear entirely. It remains the reference standard because it gives a direct tissue sample. That sample is the most concrete evidence of what the immune system has done to the gut lining. I do suspect the criteria for skipping it will keep expanding, especially for children, where avoiding anesthesia and invasive procedures matters.

What Research Gave Me

Understanding the history of the celiac biopsy did not make the endoscopy day any easier. My daughter still had to fast. She still had to wear a hospital gown and hold my hand while the anesthesiologist placed an IV. I still cried in the waiting room.

But research gave me something else. It turned the biopsy from a scary unknown into a tool with a long, documented history of helping people get answers. It helped me trust the process when the blood test had already told us so much. It also helped me explain to my daughter why we were doing it, even when she was scared. I could tell her that this small sample would show us exactly what her body was dealing with, and that knowing that would help us take care of her. And it did.

Two weeks later, the pathology report came back. Marsh 3. Villous atrophy confirmed. My daughter and I sat on the couch and read the words together. It was not a surprise, but seeing it in black and white made it real. From that day forward, we knew exactly what the gluten-free diet was for, and why every crumb mattered.

That clarity is why I started Clean Monday Meals. I started it because the answer that biopsy gave us changed how we eat, how we cook, and how we care for each other. When you know the damage, you understand the repair. And when you understand the repair, you stop feeling like food is the enemy. Food becomes part of the healing.

I am not a doctor, and I cannot tell you whether you or your child needs a biopsy. That decision belongs to the person holding the scope, not to a mom with a laptop. But if you are in the waiting room, or staring at a referral, or trying to understand why the blood test was not enough, I hope this history helps. The test has been around in some form for over sixty years because it keeps giving useful answers. It gave our family one, and it might give yours one too.

If you are newly diagnosed or starting to figure out gluten-free living, our free recipe app has hundreds of recipes that never made me miss the foods we had to leave behind. You can find it at the recipe app page. And if you are in the middle of the diagnostic process, bring a notebook. Write down your questions. The answers are there, waiting in a tiny piece of tissue.